fda warning letters glp-1 october 2025 news September 8, 2025: launches an import alert listing safe manufacturers – Partnership for Safe Medicines FDA issues 30 warning letters

Theres a new path to weight loss the GLP-1 pill

Society of You took two

Due to their glucose-lowering efficacy as well as other beneficial effects on blood pressure, body weight and lipid metabolism, they have taken a central place in the management of hyperglycemia in people with T2D

Published December 22, 2025

Accordingly, and in line with currently ongoing trials in HFpEF (ClinicalTrials.gov IDs NCT04916470 and NCT04788511), it may be relevant to consider obesity-related HFpEF as a specific (sub)phenotype, whether coexisting with type 2 diabetes or not

A real provider will have medical professionals on staff or as partners who can provide you with the consultation and prescription you want